| 注册
首页|期刊导航|哈尔滨医药|甘氨酸茶碱钠缓释片治疗支气管哮喘的效果及对氧化应激指标的影响

甘氨酸茶碱钠缓释片治疗支气管哮喘的效果及对氧化应激指标的影响

许为钊

哈尔滨医药2024,Vol.44Issue(3):29-31,3.
哈尔滨医药2024,Vol.44Issue(3):29-31,3.DOI:10.3969/j.issn.1001-8131.2024.03.010

甘氨酸茶碱钠缓释片治疗支气管哮喘的效果及对氧化应激指标的影响

Effect of Glycine Theophylline Sodium Sustained-release Tablets on Bronchial Asthma and Its Influence on Oxidative Stress Index

许为钊1

作者信息

  • 1. 普宁市人民医院,广东 揭阳 515300
  • 折叠

摘要

Abstract

Objective To understand the effect of glycine theophylline sodium sustained-release tablets in the treatment of bronchial asthma and its influence on oxidative stress indicators.Methods 100 patients with asthma were selected as study samples.The patients were divided into two groups by systematic allocation method(50 cases in the observation group and 50 cases in the control group).The observation group was treated with routine treatment plus glycine theophylline sodium sustained-release tablets,while the control group was treated with routine treatment.Results The effective rate of treatment in the observation group(96.00%)was higher than that in the control group(82.00%)(P<0.05).The time of clinical symptom disappearance in the observation group was shorter than that in the control group(P<0.05).After intervention,the indexes of lung function in the observation group were significantly better than those in the control group(P<0.05).After intervention,the inflammatory factors in the observation group were better than those in the control group(P<0.05).After intervention,the ox-idative stress index in the observation group was better than that in the control group(P<0.05).Conclusion The effect of glycine theophylline sodium sustained-release tablets in the treatment of bronchial asthma is significant,reducing inflammatory factors,improving lung function and optimizing oxidative stress indicators.

关键词

甘氨酸茶碱钠缓释片/支气管哮喘/氧化应激指标

Key words

Glycine theophylline sodium sustained-release tablets/Bronchial asthma/Oxidative stress index

分类

临床医学

引用本文复制引用

许为钊..甘氨酸茶碱钠缓释片治疗支气管哮喘的效果及对氧化应激指标的影响[J].哈尔滨医药,2024,44(3):29-31,3.

哈尔滨医药

1001-8131

访问量0
|
下载量0
段落导航相关论文